ATE482748T1 - Hemmung reaktiver sauerstoffspezies und schutz von säugerzellen - Google Patents

Hemmung reaktiver sauerstoffspezies und schutz von säugerzellen

Info

Publication number
ATE482748T1
ATE482748T1 AT06751658T AT06751658T ATE482748T1 AT E482748 T1 ATE482748 T1 AT E482748T1 AT 06751658 T AT06751658 T AT 06751658T AT 06751658 T AT06751658 T AT 06751658T AT E482748 T1 ATE482748 T1 AT E482748T1
Authority
AT
Austria
Prior art keywords
oxygen species
reactive oxygen
ros
protection
vitro
Prior art date
Application number
AT06751658T
Other languages
English (en)
Inventor
Sudipta Seal
Swanand Patil
Steve Sezate
Lily Wong
Junping Chen
James F Mcginnis
Original Assignee
Univ Central Florida Res Found
Univ Oklahoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Central Florida Res Found, Univ Oklahoma Corp filed Critical Univ Central Florida Res Found
Application granted granted Critical
Publication of ATE482748T1 publication Critical patent/ATE482748T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06751658T 2005-04-29 2006-04-27 Hemmung reaktiver sauerstoffspezies und schutz von säugerzellen ATE482748T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67604305P 2005-04-29 2005-04-29
US71663005P 2005-09-13 2005-09-13
PCT/US2006/016050 WO2006118954A2 (en) 2005-04-29 2006-04-27 Inhibition of reactive oxygen species and protection of mammalian cells

Publications (1)

Publication Number Publication Date
ATE482748T1 true ATE482748T1 (de) 2010-10-15

Family

ID=37308499

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06751658T ATE482748T1 (de) 2005-04-29 2006-04-27 Hemmung reaktiver sauerstoffspezies und schutz von säugerzellen

Country Status (7)

Country Link
US (2) US7727559B2 (de)
EP (2) EP1879570B1 (de)
AT (1) ATE482748T1 (de)
AU (1) AU2006242541B2 (de)
CA (1) CA2610296C (de)
DE (1) DE602006017199D1 (de)
WO (1) WO2006118954A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110111007A1 (en) * 2005-04-29 2011-05-12 Mcginnis James F Inhibition of retinal cell degeneration or neovascularization by cerium oxide nanoparticles
US10857178B2 (en) * 2005-06-27 2020-12-08 Edward Via Virginia College Of Osteopathic Medicine Cerium oxide nanoparticles for treatment and prevention of Alzheimer's disease, Parkinson's disease, and disorders associated with free radical production and/or mitochondrial dysfunction
WO2007002662A2 (en) * 2005-06-27 2007-01-04 Edward Via Virginia College Of Osteopathic Medicine Anti-inflammatory, radioprotective, and longevity enhancing capabilities of cerium oxide nanoparticles
US9649337B2 (en) 2005-06-27 2017-05-16 Edward Via Virginia College Of Osteopathic Medicine Cerium oxide nanoparticles for the treatment and prevention of stroke and cardiovascular disease
US7959949B2 (en) 2006-04-27 2011-06-14 University Of Central Florida Research Foundation, Inc. Functionalized nanoceria composition for ophthalmic treatment
WO2008064357A2 (en) * 2006-11-22 2008-05-29 University Of Florida Research Foundation, Inc. Nanoparticles for protection of cells from oxidative stress
WO2008083401A1 (en) 2007-01-02 2008-07-10 University Of Central Florida Research Foundation Inc. Methods and materials for stimulating proliferation of stem cells
US9119391B1 (en) 2007-07-16 2015-09-01 University Of Central Florida Research Foundation, Inc. Polymer coated ceria nanoparticles for selective cytoprotection
US8916199B1 (en) 2008-04-25 2014-12-23 University of Central Florida Research Foundation, Ind. Inhibition of angiogenesis associated with ovarian cancer by nanoparticles of cerium oxide
WO2009132277A1 (en) * 2008-04-25 2009-10-29 The Board Of Regents Of The University Of Oklahoma Inhibition of neovascularization by cerium oxide nanoparticles
US9207385B2 (en) 2008-05-06 2015-12-08 Qd Vision, Inc. Lighting systems and devices including same
WO2009151515A1 (en) 2008-05-06 2009-12-17 Qd Vision, Inc. Solid state lighting devices including quantum confined semiconductor nanoparticles
US9127202B1 (en) 2008-07-18 2015-09-08 University Of Central Florida Research Foundation, Inc. Biocompatible nano rare earth oxide upconverters for imaging and therapeutics
US20100098768A1 (en) * 2008-10-16 2010-04-22 Clarkson University Method of neuroprotection from oxidant injury using metal oxide nanoparticles
US8883519B1 (en) 2009-03-17 2014-11-11 University Of Central Florida Research Foundation, Inc. Oxidase activity of polymeric coated cerium oxide nanoparticles
WO2010129350A2 (en) 2009-04-28 2010-11-11 Qd Vision, Inc. Optical materials, optical, components, devices, and methods
US9585840B1 (en) 2009-07-10 2017-03-07 University Of Central Florida Research Foundation, Inc. Redox active cerium oxide nanoparticles and associated methods
US8795731B1 (en) 2009-10-12 2014-08-05 University Of Central Florida Research Foundation, Inc. Cerium oxide nanoparticle-based device for the detection of reactive oxygen species and monitoring of chronic inflammation
WO2012036786A1 (en) 2010-09-17 2012-03-22 University Of L'aquila Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of alzheimer's disease
US11116792B1 (en) 2010-12-22 2021-09-14 Biocurity Holdings, Inc. Cerium oxide nanoparticle formulation for use in skin radioprotection and associated methods
US8951539B1 (en) 2011-06-07 2015-02-10 University Of Central Florida Research Foundation, Inc. Methods of promoting angiogenesis using cerium oxide nanoparticles
US9161950B2 (en) 2011-09-21 2015-10-20 University Of Central Florida Foundation, Inc. Neuronal protection by cerium oxide nanoparticles
CA2869554A1 (en) 2012-04-04 2013-10-10 Duke University Methods of using cerium oxide nanoparticles to mitigate or protect against radiation injury
US9463437B2 (en) 2013-02-14 2016-10-11 University Of Central Florida Research Foundation, Inc. Methods for scavenging nitric oxide using cerium oxide nanoparticles
US9669055B1 (en) 2014-04-11 2017-06-06 Marshall University Research Corporation Methods for treating sepsis
US11389536B2 (en) 2015-07-17 2022-07-19 BioCurity Pharmaceuticals Inc. Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent
CN108685847A (zh) * 2018-06-29 2018-10-23 温州医科大学 一种针对氧化损伤诱导炎症的长效抗炎眼用分散制剂
EP4074319A1 (de) 2021-04-15 2022-10-19 Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca Ophthalmische topische zusammensetzung mit ceroxid-nanoteilchen zur behandlung von erkrankungen des hinteren augensegments

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US676043A (en) 1899-11-22 1901-06-11 John C Lincoln Electric drill.
US716630A (en) 1902-03-24 1902-12-23 August Eimer Crucible.
AU5251999A (en) * 1998-08-04 2000-02-28 Wisconsin Alumni Research Foundation Method of reducing retinal ganglion cell degeneration
EP1137395A1 (de) * 1998-12-11 2001-10-04 Cognis Deutschland GmbH Verwendung von nanoskaligen organischen uv-lichtschutzfiltern
US7930285B2 (en) * 2000-03-22 2011-04-19 Comscore, Inc. Systems for and methods of user demographic reporting usable for identifying users and collecting usage data
FR2809637B1 (fr) * 2000-06-05 2003-01-24 Rhodia Terres Rares Dispersion colloidale d'un compose de cerium ou d'un compose de cerium et d'au moins un autre element choisi parmi les terres rares et des metaux de transition et comprenant un acide amine
EP1298159A4 (de) * 2000-07-05 2004-03-31 Nippon Arc Co Ltd Transparentes mehrschichtmaterial, plastiklinse für brille und haftvermittlerzusammensetzung
US8097270B2 (en) * 2001-12-21 2012-01-17 Novartis Ag Use of nanoparticles as carriers for biocides in ophthalmic compositions
KR101087763B1 (ko) * 2002-10-28 2011-11-30 닛산 가가쿠 고교 가부시키 가이샤 산화 세륨 입자 및 그 제조방법
WO2004096146A2 (en) * 2003-04-25 2004-11-11 Nolan Gerard M Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage

Also Published As

Publication number Publication date
US20070202193A1 (en) 2007-08-30
EP2359907A1 (de) 2011-08-24
EP1879570B1 (de) 2010-09-29
US7347987B2 (en) 2008-03-25
DE602006017199D1 (de) 2010-11-11
WO2006118954A8 (en) 2007-08-23
EP1879570A2 (de) 2008-01-23
US20060246152A1 (en) 2006-11-02
US7727559B2 (en) 2010-06-01
WO2006118954A3 (en) 2007-05-24
WO2006118954A2 (en) 2006-11-09
CA2610296A1 (en) 2006-11-09
EP1879570A4 (de) 2008-10-01
CA2610296C (en) 2016-06-14
AU2006242541A1 (en) 2006-11-09
AU2006242541B2 (en) 2011-12-08

Similar Documents

Publication Publication Date Title
DE602006017199D1 (de) Hemmung reaktiver sauerstoffspezies und schutz von säugerzellen
Ishii Functional singlet oxygen generators based on phthalocyanines
He et al. Green synthesis of ultrasmall selenium nanoparticles (SeNPs) using Hericium erinaceus polysaccharide (HEP) as nanozymes for efficient intracellular antioxidation
Zholobak et al. Panthenol-stabilized cerium dioxide nanoparticles for cosmeceutic formulations against ROS-induced and UV-induced damage
Akhtar et al. Glutathione replenishing potential of CeO2 nanoparticles in human breast and fibrosarcoma cells
Monteiro et al. Titanium dioxide nanotubes incorporated into bleaching agents: physicochemical characterization and enamel color change
You et al. Core-modified porphyrins. Part 4: Steric effects on photophysical and biological properties in vitro
JP2020506953A5 (de)
ATE547107T1 (de) Verwendung von selenhefe in der behandlung von alzheimers krankheit
Johnson et al. Reduced ischemia/reperfusion injury via glutathione-initiated nitric oxide-releasing dendrimers
Zhang et al. MnO2-capped silk fibroin (SF) nanoparticles with chlorin e6 (Ce6) encapsulation for augmented photo-driven therapy by modulating the tumor microenvironment
Zhang et al. Integrated two-phase free radical hydrogel: Safe, ultra-fast tooth whitening and antibacterial activity
Zhu et al. Introducing nanozymes: new horizons in periodontal and dental implant care
Pradeep et al. Exploring plant-derived carbon dots: Dual-functional nanomaterials for endodontic infections and enhanced bio-imaging
Lv et al. Enhanced photodynamic therapy through multienzyme-like MOF for cancer treatment
Kato et al. Fullerene-C60 derivatives prevent UV-irradiation/TiO2-induced cytotoxicity on keratinocytes and 3D-skin tissues through antioxidant actions
Zhu et al. Enhanced Xanthium‐Inspired ZnO for Precision Antibacterial Therapy and Regeneration of Infected Wounds
Zhao et al. Quantum dots enhance Cu2+-induced hepatic L02 cells toxicity
Gravina et al. Protective role against hydrogen peroxide and fibroblast stimulation via Ce-doped TiO2 nanostructured materials
Huang et al. Bimetallic H-Pt3Sn nanoparticles with photothermal enhanced dual enzyme-like activities for wound healing
Abu-Taweel et al. Yttrium oxide nanoparticles moderate the abnormal cognitive behaviors in male mice induced by silver nanoparticles
Mahesh et al. Highly efficient strategy for photocatalytic tooth bleaching using SiO2/MgO/Fe2O3 nanocomposite spheres
Pugdee et al. The viability of human dental pulp cells and apical papilla cells after treatment with conventional calcium hydroxide and nanoparticulate calcium hydroxide at various concentrations
Li et al. Microenvironment responsive biomineralization nanofirework employing H2S-assisted photothermal therapy to prompt bacterial wound healing
Zhong et al. Dual-functional isoquercitin‑silver nanoparticles alleviate bacterial-induced excessive inflammation of wound infection and sepsis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties